Proven across a broad range of complex cases, the versatility of the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface* enables you to deliver high patency and durable outcomes to minimize interventions for your patients.

durable clinical study outcomes in complex cases
proven to significantly reduce reinterventions
high patency even in the most challenging disease
A leader among stent grafts with multiple indications for maximum versatility
unparalleled performance through decades of partnership with clinicians across the globe

See how the GORE® VIABAHN® Device can help you optimize clinical outcomes for your patients

viabahn stats

Performance evolution through collaboration

The GORE® VIABAHN® Device is a leader among stent grafts. Decades of partnership with clinicians around the globe has resulted in unparalleled performance across multiple indications. The GORE® VIABAHN® Device features:

  • Lengths up to 25 cm
  • Low profile design
  • Radiopaque markers
  • Proven CBAS® Heparin Surface technologyǂ
* As used by Gore, Propaten Bioactive Surface refers to Gore’s proprietary CBAS® Heparin Surface
† Data shown is representative of all generations of the device
ǂ CBAS® Heparin Surface. W. L. Gore & Associates Web site. https://goremedical.com/cbas/references. Accessed July 30, 2018.
For the approved indications of the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface see Instructions for Use. Products are CE-certified under Regulation (EU) 2017/745 (hereinafter the “MDR”). But please note that the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface that have already been placed on the market before do not require re-certification, as the MDR provides for an extended transition period (Article 120 of the MDR). Those products were marketed under a valid CE-certification under EU directive 93/42/EEC and can be used further in accordance with the label, either until product expiration or May 2025.

22461953-EN

viabahn logo